Quick Answer
LakeShore Biopharma Co., Ltd. reported Operating Income of -$12.02 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$12.02M | +97.3% |
| 2024 | -$445.83M | -219.9% |
| 2023 | -$139.38M | -17.2% |
| 2022 | -$118.96M | +5.5% |
| 2021 | -$125.85M | — |
- LakeShore Biopharma Co., Ltd. showed an increase of +97.3% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, LakeShore Biopharma Co., Ltd.’s operating income has grown by 90.4% (from -$125.85 million to -$12.02 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: